DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 129 filers reported holding DENALI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 258.00 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,359,100 | +5.9% | 162,826 | +51.5% | 0.00% | 0.0% |
| Q2 2023 | $3,171,794 | -0.3% | 107,482 | -22.2% | 0.00% | 0.0% |
| Q1 2023 | $3,181,179 | +98.3% | 138,072 | +139.3% | 0.00% | +100.0% |
| Q4 2022 | $1,604,303 | -100.0% | 57,688 | -46.9% | 0.00% | -60.0% |
| Q3 2022 | $3,331,983,000 | +407.0% | 108,569 | +386.2% | 0.01% | +400.0% |
| Q2 2022 | $657,231,000 | +147.8% | 22,332 | +170.9% | 0.00% | – |
| Q1 2022 | $265,177,000 | -69.8% | 8,243 | -58.2% | 0.00% | -100.0% |
| Q4 2021 | $878,575,000 | -3.2% | 19,699 | +9.4% | 0.00% | 0.0% |
| Q3 2021 | $908,050,000 | +91.4% | 17,999 | +197.6% | 0.00% | 0.0% |
| Q2 2021 | $474,405,000 | -23.8% | 6,048 | -44.5% | 0.00% | 0.0% |
| Q1 2021 | $622,504,000 | -24.9% | 10,902 | +10.2% | 0.00% | -50.0% |
| Q4 2020 | $828,889,000 | +55.2% | 9,896 | -33.6% | 0.00% | +100.0% |
| Q3 2020 | $533,939,000 | +234.6% | 14,902 | +125.8% | 0.00% | – |
| Q2 2020 | $159,564,000 | -59.6% | 6,599 | -70.8% | 0.00% | -100.0% |
| Q1 2020 | $395,393,000 | +220.6% | 22,581 | +219.0% | 0.00% | – |
| Q4 2019 | $123,316,000 | -8.3% | 7,079 | -19.4% | 0.00% | – |
| Q3 2019 | $134,479,000 | -0.5% | 8,778 | +34.8% | 0.00% | – |
| Q2 2019 | $135,189,000 | -45.4% | 6,512 | -38.9% | 0.00% | -100.0% |
| Q1 2019 | $247,432,000 | +909.8% | 10,656 | +798.5% | 0.00% | – |
| Q4 2018 | $24,503,000 | -37.0% | 1,186 | -33.7% | 0.00% | – |
| Q3 2018 | $38,871,000 | +103.7% | 1,788 | +42.9% | 0.00% | – |
| Q2 2018 | $19,078,000 | -68.4% | 1,251 | -59.2% | 0.00% | – |
| Q1 2018 | $60,330,000 | – | 3,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |